Siloxane derivatives of amino acids having surface-active properties

US11008348B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11008348-B2
Application numberUS-202016990855-A
CountryUS
Kind codeB2
Filing dateAug 11, 2020
Priority dateAug 22, 2019
Publication dateMay 18, 2021
Grant dateMay 18, 2021

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides siloxane derivatives of amino acids that have surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of a lactam, such as caprolactam. The amino acid may be functionalized with a siloxane group to form a compound that is surface-active and has surfactant characteristics. The compounds have low critical micelle concentrations (CMC) as well as the ability to lower the surface tension of a liquid.

First claim

Opening claim text (preview).

The invention claimed is: 1. A compound of Formula I: wherein R 1 and R 2 may be the same or different, and comprise at least one group selected from the group consisting of C 1 -C 6 alkyl, optionally the C 1 -C 6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; n is an integer from 3 to 12; the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, hydroxyl, and C 1 -C 6 alkyl; and an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, and iodide. 2. The compound of claim 1 , represented by Formula Ia: wherein R 1 and R 2 may be the same or different, and comprise at least one group selected from the group consisting of C 1 -C 6 alkyl, optionally the C 1 -C 6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; m is an integer from 3 to 6; the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, and C 1 -C 6 alkyl wherein the alkyl chain is optionally substituted with one or more substituents selected from the group consisting of carboxyl, carboxylate, and sulfonate; and an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, and iodide. 3. The compound of claim 1 , represented by the following Formula Ib: wherein R 1 and R 2 may be the same or different, and comprise at least one group selected from the group consisting of C 1 -C 6 alkyl, optionally the C 1 -C 6 alkyl may include one or more of oxygen, nitrogen, or sulfur atoms or groups that include at least one of these atoms, and the alkyl chain may be optionally substituted with one or more substituents selected from the group consisting of hydroxyl, amino, amido, sulfonyl, sulfonate, carbonyl, carboxyl, and carboxylate; p is 5; the terminal nitrogen is optionally further substituted with R 3 , wherein R 3 is selected from the group consisting of hydrogen, oxygen, and C 1 -C 6 alkyl, wherein the alkyl chain is optionally substituted with one or more substituents selected from the group consisting of carboxyl, carboxylate, and sulfonate; and an optional counterion associated with the compound which, if present, is selected from the group consisting of chloride, bromide, and iodide. 4. The compound of claim 1 , wherein R 1 and R 2 are methyl. 5. The compound of claim 1 , wherein n is 5. 6. The compound of claim 5 , wherein R 3 is hydrogen. 7. The compound of claim 6 , wherein the counterion is selected from the group consisting of chloride, bromide, and iodide. 8. The compound of claim 7 , wherein the counterion is chloride. 9. The compound of claim 5 , wherein R 3 is methyl. 10. The compound of claim 9 , wherein the counterion is selected from the group consisting of chloride, bromide, and iodide. 11. The compound of claim 10 , wherein the counterion is iodide. 12. The compound of claim 5 , wherein R 3 is an oxygen atom. 13. The compound of claim 5 , wherein R 3 is C 1 -C 6 alkyl, substituted with sulfonate. 14. The compound of claim 5 , wherein the compound is 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethyl silyl)oxy)trisiloxan-3-yl)propyl)hexanamide, having the following formula: 15. The compound of claim 8 , wherein the compound is 6-(dimethylamino)-N-(3-(1,1,1,5,5,5-hexamethyl-3-((trimethyl silyl)oxy)trisiloxan-3-yl)propyl)hexaminium chloride, having the following formula: 16. The compound of claim 11 , wherein the compound is 3 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N,N-trimethyl-6-oxohexan-1-aminium iodide, having the following formula: 17. The compound of claim 12 , wherein the compound is 6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl)propyl)amino)-N,N-dimethyl-6-oxohexan-1-amine oxide, having the following formula: 18. The compound of claim 13 , wherein the compound is 4-((6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethyl silyl)oxy)trisiloxan-3-yl)propyl)amino)-6-oxohexyl)dimethylammonio)butane-1-sulfonate, having the following formula: 19. The compound of claim 13 , wherien the compound is 5-((6-((3-(1,1,1,5,5,5-hexamethyl-3-((trimethylsilyl)oxy)trisiloxan-3-yl) propyl)amino-6- oxohexyl)dimethylammonio)pentane-1-sulfonate, having the following formula:

Assignees

Inventors

Classifications

  • Silicon compounds · CPC title

  • Treatments not covered by a preceding group · CPC title

  • Aminocarboxylic acids (proteins and protein hydrolysates C09K23/30) · CPC title

  • C07F7/0838Primary

    Compounds with one or more Si-O-Si sequences (compounds with a ring containing only alternating Si and O atoms, i.e. cyclosilanes C07F7/21) · CPC title

  • C07F7/0834Primary

    Compounds having one or more O-Si linkage (for compounds with C-O-Si linkages see C07F7/18) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11008348B2 cover?
The present disclosure provides siloxane derivatives of amino acids that have surface-active properties. The amino acid can be naturally-occurring or synthetic, or they may be obtained via a ring-opening reaction of a lactam, such as caprolactam. The amino acid may be functionalized with a siloxane group to form a compound that is surface-active and has surfactant characteristics. The compounds…
Who is the assignee on this patent?
Advansix Resins & Chemicals Llc
What technology area does this patent fall under?
Primary CPC classification C07F7/0838. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).